Innate Pharma (IPHA) Price to Sales (2024 - 2025)
Innate Pharma's Price to Sales came in at 2.72 for the quarter ended Dec 31, 2025, up 7.7% from 2.53 a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Price to Sales (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innate Pharma's Price to Sales was 16.12, up 127.6% from the prior year.
- Going back by year, Price to Sales was 7.08 in the year ended Dec 31, 2024 (+109.6%), 3.38 in the year ended Dec 31, 2023 (-30.8%), 4.88 in the year ended Dec 31, 2022 (-62.0%) and 12.84 in the year ended Dec 31, 2021 (+216.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Innate Pharma | 152.76 Mn | 152.76 Mn | - |
API Access
Innate Pharma Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();